Engineered Mesenchymal Stem Cell‐Derived Extracellular Vesicles Scavenge Self‐Antigens for Psoriasis Therapy via Modulating Metabolic and Immunological Disorders (Adv. Sci. 6/2025)
Novel Therapy for Psoriasis In article number 2410067, Xin Zhou, Yunsheng Xu, Danyang Li, and co‐workers present a novel engineered mesenchymal stem cell‐derived extracellular vesicles for treating psoriasis, a condition currently lacks a complete cure. This approach can effectively reduce psoriasis‐specific self‐antigens and modulate both metabolic and immunological disorders, thereby providing new insights for psoriasis therapy. [Image: see text]
Authors
- Rongying Ou (ORCID: https://orcid.org/0000-0003-0174-7088)
- Chongchao Hou
- Qing Yu Huang (ORCID: https://orcid.org/0000-0002-0140-8978)
- Zhihong Yao (ORCID: https://orcid.org/0000-0001-5999-4466)
- Lizhou Xu (ORCID: https://orcid.org/0000-0001-5983-4059)
- Guanqiao Shan (ORCID: https://orcid.org/0000-0002-2570-769X)
- Xuankai Liao
- Siyu Yang (ORCID: https://orcid.org/0000-0002-4115-7915)
- Cheng Zou
- Danyang Li (ORCID: https://orcid.org/0000-0002-7508-6019)
- Bo Tang (ORCID: https://orcid.org/0000-0002-8712-7025)
- Xin Zhou (ORCID: https://orcid.org/0009-0001-6090-0460)
- Yunsheng Xu (ORCID: https://orcid.org/0000-0001-7423-2988)
- Wen Chen (ORCID: https://orcid.org/0000-0001-5435-1664)
- Yang Jiang (ORCID: https://orcid.org/0000-0002-9443-3696)
Publication Details
- Journal
- Advanced Science
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1002/advs.202570031
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00